摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-Butoxy-6-methoxy-1-methyl-isoquinolin-3-ol | 114130-64-2

中文名称
——
中文别名
——
英文名称
7-Butoxy-6-methoxy-1-methyl-isoquinolin-3-ol
英文别名
7-Butoxy-6-methoxy-1-methyl-3(2h)-isoquinolinone;7-butoxy-6-methoxy-1-methyl-2H-isoquinolin-3-one
7-Butoxy-6-methoxy-1-methyl-isoquinolin-3-ol化学式
CAS
114130-64-2
化学式
C15H19NO3
mdl
——
分子量
261.321
InChiKey
OLUNIANQQXUVBV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Isoquinolinol derivatives: potent, short-acting inotropic and vasodilating agents with potential utility for cardiac emergencies
    摘要:
    The synthesis and cardiovascular evaluation of a series of 4-nitroisoquinolin-3-ol derivatives are reported. These compounds are potent, short-acting cardiovascular agents with both positive inotropic and peripheral vasodilating effects when administered intravenously. Compounds with this profile could be of particular therapeutic benefit in cardiac emergencies such as severe late stage heart failure and myocardial infarction. Of particular interest is 7-ethoxy-6-methoxy-1-methyl-4-nitroisoquinolin-3-ol (6) which has potent, non beta-adrenergic parenteral inotropic properties similar to those of dopamine, and also has peripheral vasodilator activity, up to 10-fold greater than amrinone.
    DOI:
    10.1016/0223-5234(91)90023-g
  • 作为产物:
    描述:
    (4-Butoxy-3-methoxy-phenyl)-acetic acid methyl ester 在 ammonium hydroxide高氯酸 作用下, 以 为溶剂, 生成 7-Butoxy-6-methoxy-1-methyl-isoquinolin-3-ol
    参考文献:
    名称:
    强心剂。一系列异喹啉-3-醇衍生物的合成和正性活性。
    摘要:
    制备了一系列异喹啉-3-醇衍生物(II)作为临床强心药贝马龙酮(ORF 16600,I)的类似物。尽管在许多方面,II的强心活性的结构要求与贝马龙酮相似,但仍需注意系列之间的某些差异。我们的结构活性研究表明,II对烷氧基取代作用的敏感性不如I,并且更重要的是,与I相比,烷基,卤素或烷烃羧酸衍生物对II进行的4取代增强了II的心脏活性,其中类似的取代消除了活性。确定了收缩力(CF)增加与环状核苷酸磷酸二酯酶组分III(PDE-III)对标题化合物的抑制之间的线性关系。
    DOI:
    10.1021/jm00402a020
点击查看最新优质反应信息

文献信息

  • KANOJIA, RAMESH M.;PRESS, JEFFERY B.;LEVER, O. WILLIAM, JR.;WILLIAMS, LOU+, J. MED. CHEM., 31,(1988) N 7, 1363-1368
    作者:KANOJIA, RAMESH M.、PRESS, JEFFERY B.、LEVER, O. WILLIAM, JR.、WILLIAMS, LOU+
    DOI:——
    日期:——
  • Isoquinolinol derivatives: potent, short-acting inotropic and vasodilating agents with potential utility for cardiac emergencies
    作者:RM Kanojia、JB Press、OW Lever、L Williams、HM Werblood、R Falotico、JM Moore、AJ Tobia
    DOI:10.1016/0223-5234(91)90023-g
    日期:1991.3
    The synthesis and cardiovascular evaluation of a series of 4-nitroisoquinolin-3-ol derivatives are reported. These compounds are potent, short-acting cardiovascular agents with both positive inotropic and peripheral vasodilating effects when administered intravenously. Compounds with this profile could be of particular therapeutic benefit in cardiac emergencies such as severe late stage heart failure and myocardial infarction. Of particular interest is 7-ethoxy-6-methoxy-1-methyl-4-nitroisoquinolin-3-ol (6) which has potent, non beta-adrenergic parenteral inotropic properties similar to those of dopamine, and also has peripheral vasodilator activity, up to 10-fold greater than amrinone.
  • Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives
    作者:Ramesh M. Kanojia、Jeffery B. Press、O. William Lever、Louella Williams、James J. McNally、Alfonso J. Tobia、Robert Falotico、John B. Moore
    DOI:10.1021/jm00402a020
    日期:1988.7
    acid derivatives enhances cardiotonic activity in II in contrast to I, wherein analogous substitution eliminated activity. A linear correlation between contractile force (CF) increase and cyclic nucleotide phosphodiesterase fraction III (PDE-III) inhibition by the title compounds was determined. The isoquinoline derivatives were characteristically short-acting cardiotonic agents with good potency and
    制备了一系列异喹啉-3-醇衍生物(II)作为临床强心药贝马龙酮(ORF 16600,I)的类似物。尽管在许多方面,II的强心活性的结构要求与贝马龙酮相似,但仍需注意系列之间的某些差异。我们的结构活性研究表明,II对烷氧基取代作用的敏感性不如I,并且更重要的是,与I相比,烷基,卤素或烷烃羧酸衍生物对II进行的4取代增强了II的心脏活性,其中类似的取代消除了活性。确定了收缩力(CF)增加与环状核苷酸磷酸二酯酶组分III(PDE-III)对标题化合物的抑制之间的线性关系。
查看更多